Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

200.91 -2.28 (-1.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
21 22 Next >
News headline image
Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
From Natera, Inc.
Via Business Wire
News headline image
Natera to Report its Second Quarter 2024 Results on August 8, 2024
From Natera, Inc.
Via Business Wire
News headline image
New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
From Natera, Inc.
Via Business Wire
News headline image
(NTRA) - Analyzing Natera's Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today ↗
 
Via Benzinga
News headline image
The 3 Best Gene Editing Stocks to Buy in July 2024 ↗
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
Via InvestorPlace
News headline image
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
From Natera, Inc.
Via Business Wire
News headline image
Trading SMID Biotech Stocks In A Volatile Market ↗
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... 
Via Talk Markets
News headline image
Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
From Natera, Inc.
Via Business Wire
News headline image
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including 
Via MarketBeat
News headline image
Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
From Natera, Inc.
Via Business Wire
News headline image
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,400 Today ↗
 
Via Benzinga
News headline image
Amazon, Natera And A Financial Stock: CNBC's 'Final Trades' ↗
The recommendation comes after a former Amazon employee accused the Seattle-based company of selling technology to Russia. 
Via Benzinga
News headline image
Breaking Down Natera: 10 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
(NTRA) - Analyzing Natera's Short Interest ↗
 
Via Benzinga
News headline image
Key Takeaways From Natera Analyst Ratings ↗
 
Via Benzinga
News headline image
Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
From Natera, Inc.
Via Business Wire
News headline image
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action ↗
On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhood Markets Inc (NASDAQ:HOOD) shares. 
Via Benzinga
News headline image
Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
From Natera, Inc.
Via Business Wire
News headline image
Ford Motor, Microsoft And 2 Other Stocks Insiders Are Selling ↗
 
Via Benzinga
News headline image
Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting
From Natera, Inc.
Via Business Wire
News headline image
NATERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Natera, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise ↗
The company put up a "robust" beat and raise following an increase in test volume and sales prices in women's health and cancer detection. 
Via Investor's Business Daily
News headline image
Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.